(MENAFN- iCrowdNewsWire)

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the“Global Digital Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Sleep Tracking Apps. Relaxation and Meditation Apps, CBT-I, Wearable Devices), Distribution Channel (Mobile App Stores, Healthcare Providers and Clinics, and Other Distribution Channels), Region, Market Outlook and Industry Analysis 2031′′

The global Digital Insomnia Therapeutics market is estimated to reach over USD 5.16 billion by the year 2031 exhibiting a CAGR of 5.6% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC:

Insomnia is a prevalent sleep disorder characterized by difficulties in initiating or maintaining sleep, often resulting in persistent fatigue, excessive daytime sleepiness, mood disturbances such as irritability and depression, and reduced energy levels.

This condition affects millions globally and can stem from various underlying factors, including chronic pain, hyperthyroidism, menopause, psychological stress, and disruptions to the circadian rhythm. Lifestyle behaviors, including high consumption of caffeine, alcohol, and nicotine, may further exacerbate or trigger the disorder.

Diagnosis of insomnia is typically conducted at specialized sleep centers utilizing advanced diagnostic techniques. The insomnia therapeutics market is being driven by several factors, including advancements in medical technologies, a growing aging population, increased availability of patented pharmaceutical compounds, and a robust pipeline of investigational drug candidates in clinical development.

Rising stress levels and heightened awareness of the adverse effects of sleep deprivation on overall health and daily functioning are further fueling market expansion. As a result, the global insomnia therapeutics market is expected to experience consistent revenue growth over the forecast period.

List of Prominent Players in the Digital Insomnia Therapeutics Market:

• Headspace Inc.
• Big Health
• Calm
• Nox Health
• Pear Therapeutics Inc.
• OPTT Inc.
• SilverCloud
• Curv Health
• Bodymatter, Inc.
• PrimeNap

Expert Knowledge, just a Click Away:

Market Dynamics

Drivers:

The digital therapeutics segment is experiencing sustained growth, driven by its capacity to facilitate behavioral modification, enhance patient convenience, improve medication adherence, and deliver user-friendly interfaces. Advances in technology, particularly the widespread adoption of smartphones and tablets, have enabled healthcare applications that support the diagnosis, treatment, and management of a wide range of medical conditions.

These solutions allow for continuous monitoring and recording of vital signs without direct clinical intervention, support mobile consultations, and optimize chronic disease management. Additionally, digital therapeutics offer pharmaceutical companies' opportunities to extend product life cycles, differentiate pipeline offerings, and address therapeutic areas not fully served by conventional treatments.

Challenges:

Despite their promise, digital therapeutics face regulatory and reimbursement challenges that may hinder broad adoption. Approval, validation, and reimbursement procedures vary across jurisdictions, potentially slowing market entry. Although digital interventions for conditions such as insomnia demonstrate potential, extensive clinical validation is essential to establish efficacy and safety. High-quality, evidence-based clinical trials remain critical for regulatory approval, professional acceptance, and stakeholder confidence.

Regional Trends:

North America currently dominates the global insomnia therapeutics market in terms of revenue. This leadership is supported by rising healthcare expenditures, increasing prevalence of sleep disorders, heightened awareness of the health consequences of insufficient sleep, and growing demand for effective therapeutic interventions in the United States and Canada.

The expanding geriatric population, particularly in the U.S., coupled with a high incidence of insomnia among older adults, is expected to further drive demand. Supportive reimbursement policies, a strong clinical development pipeline, and rising stress levels within the population also contribute to sustained market growth in the region.

Unlock Your GTM Strategy:

Recent Developments:

• In May 2022, QUVIVIQ, which is intended for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and a significant impact on daytime functioning, was given marketing permission by the European Commission to Idorsia Ltd.
• In January 2022, The United States Food and Drug Administration gave Idorsia permission to market QUVIVIQ 25 and 50 mg for the treatment of individuals with insomnia who have trouble falling asleep or staying asleep.

Segmentation of Digital Insomnia Therapeutics Market-

By Type-

• Sleep Tracking Apps
• Relaxation and Meditation Apps
• Cognitive-Behavioral Therapy for Insomnia (CBT-I)
• Wearable Devices
• Others

By Distribution Channel-

• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channel

By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Tags: Digital Insomnia Therapeutics Market See Campaign:
Contact Information:

Contact us: InsightAce Analytic Pvt. Ltd. Visit: Tel : +1 607 400-7072 Asia: +91 79 72967118 ...

Tags:
CE , Go Media , Go Media2 , iCN Internal Distribution , Reportedtimes , Research Newswire , English

MENAFN10102025003318003403ID1110179874